Cascade Pharmaceuticals, Inc
Clinical trials sponsored by Cascade Pharmaceuticals, Inc, explained in plain language.
-
New hope for liver disease patients: Final-Stage trial tests promising drug
Disease control Recruiting nowThis study is testing if a new drug called CS0159 can help control primary biliary cholangitis (PBC), a liver disease, in people who don't respond well to or can't tolerate the standard medication. About 135 participants will be randomly assigned to receive either CS0159 or a pla…
Phase: PHASE3 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill tested to fight fatty liver disease
Disease control Recruiting nowThis study is testing an investigational drug called CS060380 tablets to see if it can help treat NASH, a serious form of fatty liver disease. About 120 adults with NASH will take either the study drug or a placebo (a dummy pill) daily for 12 weeks. Researchers will use special M…
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC